Type 3 Cannabis Chemotype

Type 3 cannabis chemotypes are characterized by relatively balanced or intermediate ratios of THC to CBD, though nomenclature varies across research and breeding communities. Early cannabis taxonomy systems, particularly those developed in the 1970s-80s, classified plants into chemotype categories based on cannabinoid profiles rather than morphology alone. Type 3 plants commonly fall into intermediate profiles where neither THC nor CBD dramatically dominates the cannabinoid expression. This classification reflects the genetic complexity of cannabinoid synthesis pathways and the polygenic nature of cannabinoid ratios in cannabis. Understanding chemotypes remains foundational to modern breeding programs seeking specific cannabinoid targets.

Breeders working toward balanced or CBD-forward cultivars frequently reference chemotype classifications when selecting parental stock and tracking cannabinoid inheritance patterns. Type 3 designations help document cannabinoid expression stability across generations, supporting the development of consistent, predictable lineages.